Leading UK-Based Renewable Energy Company Selects ServicePower’s Vision AI for Smart Meter Rollout
Computer Vision Solution to Enhance Safety and Reduce Risk for Smart Meter Installations MCLEAN, Va., Oct. 6, 2025 /PRNewswire/ — ServicePower, a leading provider... Read more.
EDX Markets Appoints David Olsson as Chief Commercial Officer
CHICAGO, Oct. 6, 2025 /PRNewswire/ — EDX Markets, a leading digital asset technology firm that combines an institutional-only trading venue with a central... Read more.
Novel Long RNA Manufacturing Approaches for Advancing RNA Therapeutics, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how innovative long RNA manufacturing approaches can drive the development of next-generation RNA medicines. Attendees will understand... Read more.
MediView Closes $24 Million Series A to Redefine Surgical Navigation and Medical Imaging with Augmented Reality
MediView secures $24M Series A led by GE HealthCare, Mayo Clinic, and Cleveland Clinic to revolutionize image-guided surgery through augmented reality and AI. AR-powered... Read more.
Toledo Athletics Names Event Tickets Center Its Official Ticket Partner of Athletics
TOLEDO, Ohio, Oct. 6, 2025 /PRNewswire/ — Event Tickets Center (ETC), the trusted marketplace for live event tickets that connects fans with unforgettable... Read more.
QYOU Media Subsidiary Chatterbox Technologies Completes Successful India IPO
Oversubscribed Issue Drives 17% Two Day Gain From Top End of Initial Pricing Over 2.1M Shares Traded Representing Buying of Over $4.2M CAD Over First Two Days... Read more.
SAXON CAPITAL GROUP, INC. EXPANDS FURTHER INTO THE HOME BUILDING SECTOR BY INTRODUCING NEW AND LARGER SOLAR POWERED HOMES
Solar Home Builders Expands Residential Line with New Solar-Enhanced Duplexes, Condominiums, And off the Grid Homes. SCOTTSDALE, Ariz., Oct. 6, 2025 /PRNewswire/... Read more.
Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA® (valbenazine) Capsules for Huntington’s Disease Chorea
Once-daily INGREZZA treatment was generally well tolerated and showed early and sustained improvements in chorea severity Findings presented at 2025 MDS International... Read more.
Myrtelle Announces Presentation of Encouraging Interim Results from its Phase 1/2 Gene Therapy Trial for Canavan Disease at the 2025 Cell & Gene Meeting on the Mesa
NEW YORK, Oct. 6, 2025 /PRNewswire/ — Myrtelle Inc. (“Myrtelle” or the “Company”), a gene therapy company pioneering transformative... Read more.
Entreprenista 100 Awards Now Accepting Applications from Accomplished Women Founders
The Entreprenista 100 Awards highlights the Top 100 Women Business Owners of 2025 NEW YORK, Oct. 6, 2025 /PRNewswire/ — The Entreprenista League, a leading... Read more.